These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2052525)

  • 1. Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects.
    Coupe AJ; Davis SS; Wilding IR
    Pharm Res; 1991 Mar; 8(3):360-4. PubMed ID: 2052525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal transit of model mini-tablet controlled release oral dosage forms in fasted human volunteers.
    Podczeck F; Course N; Newton JM; Short MB
    J Pharm Pharmacol; 2007 Jul; 59(7):941-5. PubMed ID: 17637188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
    Kambayashi A; Blume H; Dressman J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transit of pharmaceutical dosage forms through the small intestine.
    Davis SS; Hardy JG; Fara JW
    Gut; 1986 Aug; 27(8):886-92. PubMed ID: 3732895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of colonic transit of nondisintegrating tablets in healthy subjects.
    Price JM; Davis SS; Wilding IR
    Dig Dis Sci; 1993 Jun; 38(6):1015-21. PubMed ID: 8389686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Diurnal Variation and Food on Gastrointestinal Transit of
    Kambayashi A; Sako K; Kondo H
    J Pharm Sci; 2020 Feb; 109(2):1020-1025. PubMed ID: 31600549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of phenylpropanolamine bioavailability with gastrointestinal transit by scintigraphic monitoring of 111In-labeled hydroxypropylmethylcellulose matrices.
    Feely LC; Davis SS
    Pharm Res; 1989 Apr; 6(4):274-8. PubMed ID: 2748514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the gastrointestinal transit and disintegration behavior of floating and sinking acid-resistant capsules using a novel MRI labeling technique.
    Grimm M; Ball K; Scholz E; Schneider F; Sivert A; Benameur H; Kromrey ML; Kühn JP; Weitschies W
    Eur J Pharm Sci; 2019 Mar; 129():163-172. PubMed ID: 30639530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal transit of dosage forms in the pig.
    Davis SS; Illum L; Hinchcliffe M
    J Pharm Pharmacol; 2001 Jan; 53(1):33-9. PubMed ID: 11206190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meal-induced acceleration of tablet transit through the human small intestine.
    Fadda HM; McConnell EL; Short MD; Basit AW
    Pharm Res; 2009 Feb; 26(2):356-60. PubMed ID: 18982248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of gamma scintigraphy to follow the gastrointestinal transit of pharmaceutical formulations.
    Christensen FN; Davis SS; Hardy JG; Taylor MJ; Whalley DR; Wilson CG
    J Pharm Pharmacol; 1985 Feb; 37(2):91-5. PubMed ID: 2858556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal transit of Sinemet CR in healthy volunteers.
    Wilding IR; Davis SS; Melia CD; Hardy JG; Evans DF; Short AH; Sparrow RA
    Neurology; 1989 Nov; 39(11 Suppl 2):53-8. PubMed ID: 2685651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of small intestinal transit and colon arrival times of non-disintegrating tablets administered in the fasted state.
    Pišlar M; Brelih H; Mrhar A; Bogataj M
    Eur J Pharm Sci; 2015 Jul; 75():131-41. PubMed ID: 25769525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of gender, age, and body mass index on gastrointestinal transit times.
    Madsen JL
    Dig Dis Sci; 1992 Oct; 37(10):1548-53. PubMed ID: 1396002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric emptying and intestinal transit of pancreatic enzyme supplements in cystic fibrosis.
    Taylor CJ; Hillel PG; Ghosal S; Frier M; Senior S; Tindale WB; Read N
    Arch Dis Child; 1999 Feb; 80(2):149-52. PubMed ID: 10325730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo evaluation of the absorption and gastrointestinal transit of avitriptan in fed and fasted subjects using gamma scintigraphy.
    Marathe PH; Sandefer EP; Kollia GE; Greene DS; Barbhaiya RH; Lipper RA; Page RC; Doll WJ; Ryo UY; Digenis GA
    J Pharmacokinet Biopharm; 1998 Feb; 26(1):1-20. PubMed ID: 9773390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractional gastrointestinal transit time: intra- and interindividual variation.
    Birkebaek NH; Memmert K; Mortensen J; Dirksen H; Christensen MF
    Nucl Med Commun; 1990 Mar; 11(3):247-52. PubMed ID: 2342723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between intestinal pH, transit time and feed status on the in vivo performance of pH responsive ileo-colonic release systems.
    Ibekwe VC; Fadda HM; McConnell EL; Khela MK; Evans DF; Basit AW
    Pharm Res; 2008 Aug; 25(8):1828-35. PubMed ID: 18465212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral modified-release formulations in motion: the relationship between gastrointestinal transit and drug absorption.
    Varum FJ; Merchant HA; Basit AW
    Int J Pharm; 2010 Aug; 395(1-2):26-36. PubMed ID: 20546855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transit of dosage forms through the small intestine.
    Yuen KH
    Int J Pharm; 2010 Aug; 395(1-2):9-16. PubMed ID: 20478371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.